Ivermectin internal emails at Health Canada

during the height of vaccine pandemonium: Jan-Sep 2021

This article has HC emails re ivermectin. Find PHAC emails re ivm here: June 2022 and Aug 2022.

---

The following info package was released by the Canadian government in Jan 2023. It required an official complaint to the Information Commissioner and ~16 months wait. But even government can move eventually! Thanks guys

The full package is downloadable below, in four parts.

Takeaways:

• Health Canada is well aware of the public’s desire for ivermectin to treat covid

• Health Canada - like PHAC - is aware of credible evidence that ivermectin significantly reduces mortality, yet proclaims “There is no evidence that ivermectin works to prevent or treat COVID-19, and it is not authorized for this use.”

• Health Canada searched for evidence that ivermectin is dangerous and found none (0 adverse events of any kind for oral ivermectin, 7 non-serious reports for topical ivermectin), yet says it “may cause serious health problems”

• Health Canada correctly says it has no jurisdiction over doctors using ivermectin to treat covid off-label, yet provincial regulators (the ‘Colleges’) rely on Health Canada guidance when persecuting the brave doctors who prescribe the drug

Nobel-prize winning ivermectin - a WHO ‘essential medicine’ since 1987 - is very difficult to obtain in Canada. Three years in, the first-line medicine is unavailable. Meanwhile, Health Canada counts hundreds of covid deaths every week.

---

At one point it was said there were >40,000 pages under review for this release. 1,302 pages survived the gauntlet, with lots of duplicated messages across email threads. Further redactions are peppered throughout, including under s. 69 of the Access to Info Act (‘cabinet confidence’, ie., elite secrecy).

Nevertheless, this glance inside confirms what many of us suspected.

Part 1 / 4 - ATIP HC Release re IVM - 1Jan21-25Sep21

51.8MB ∙ PDF file

Download

Part 1, pages 1-326, non-searchable

Download

Part 2 / 4 - ATIP HC Release re IVM - 1Jan21-25Sep21

54.7MB ∙ PDF file

Download

Part 2, pages 327-652, non-searchable

Download

Part 3 / 4 - ATIP HC Release re IVM - 1Jan21-25Sep21

54.9MB ∙ PDF file

Download

Part 3, pages 653-978, non-searchable

Download

Part 4 / 4 - ATIP HC Release re IVM - 1Jan21-25Sep21

66.2MB ∙ PDF file

Download

Part 4, pages 979-1302, non-searchable

Download

Highlights have been extracted below for your perusal. Cutoff date is 25 Sep 2021.

Part 1 / 4

Part 1, page 5

Part 1, page 6 — Link referenced

Part 1, page 54, cherry picking studies — Link

Part 1, page 55

Part 1, page 58

Part 1, page 71 — Redactions are made under s. 69 of the Act (cabinet confidence). References to “COVID-19 interim orders” and “July 31st NOI” (scroll to Department of Health). Interim orders are Canadian equivalent of U.S. ‘emergency use authorization’ (EUA)

Part 1, pages 85-86 — Health Canada knew about PHAC’s findings

Part 1, pages 87-88

Part 1, page 88

Part 1, page 88-89

Part 1, pages 89-90

Part 1, page 91

Part 1, page 92

Part 1, page 93

Part 1, page 94

Part 1, pages 97-98

Part 1, page 97

Part 1, page 100

Part 1, page 103

Part 1, page 119

Part 1, page 143

Part 1, pages 156-157 — CBC article

Part 1, page 176

Part 1, page 178

Part 1, page 178

Part 1, pages 186-187 — Redaction under s. 19(1) (personal information)

Part 1, pages 203-204

Part 1, page 203

Part 1, page 204

Part 1, page 206

Part 1, page 215 — medscape article

Part 1, page 218

Part 1, page 225

Part 1, page 228

Part 1, page 232 — Coordination with other regulators

Part 1, page 239 — HC via PHAC knew that ivm can reduce deaths by two-thirds

Part 1, page 249

Part 1, 250

Part 1, page 251 — 7 adverse event reports received by HC over 15 months. How many adverse event reports did they receive re the vax over 15 months?

Part 1, page 254 — Further down we find that oral ivermectin had 0 (zero) reactions reported. All 7 non-serious reports were from topical ivermectin.

Part 1, page 292

Part 1, page 295

Part 1, page 303 — Deflection

Part 1, page 326 — This all-time search for ivm adverse events was also requested, but the results don’t appear to be shared in the package

Part 2 / 4

Part 2, page 4

Part 2, pages 12-13

Part 2, page 22

Part 2, page 37

Part 2, page 43 — Desperately looking for ivermectin adverse events

Part 2, page 84 — More difficulties finding safety problems with ivermectin

Part 2, page 91

Part 2, page 188

Part 2, page 191

Part 2, page 217

Part 2, page 220

Part 2, page 229 — Does the same apply to vaccines?

Part 3 / 4

Part 3, page 9 — Ivermectin prescription data from CDC

Part 3, page 12

Part 3, page 16

Part 3, page 235

Part 3, page 286 — A helpful member of the public

Part 3, page 295

Part 3, page 297

Part 3, page 307

Part 3, page 318

Part 3, page 325

Part 4 / 4

Part 4, page 4 — Government is still ignoring the RCTs at the peril of Canadians

Part 4, page 31

Part 4, pages 36-37

Part 4, page 39

Part 4, page 40 — C-span link (the other links are currently dead)

Part 4, page 42

Part 4 page 46 — Curious redactions under s. 23 (solicitor-client privilege)

Part 4, page 47 — More s. 23 redactions

Part 4, page 48 — Lawyer advising on something ivermectin-related

Part 4, pages 49-52 — All solicitor-client privilege

Part 4, page 53 — Page(s) withheld altogether

Part 4, page 62

Part 4, page 188

Part 4, page 204

Part 4, pages 204-205

Part 4, page 236

---

Find ivermectin emails from Public Health Agency of Canada here and here.

Scoops McGoo on twitter